PRISMAP: A European network for medical radioisotope production and research

October 1, 2021, 12:00PMNuclear News
A conceptual image of collaboration across Europe. (Image: PRISMAP/SCIPROM)

Only a few of the more than 3,000 radioisotopes that scientists have synthesized in the laboratory are regularly used in diagnostic or therapeutic medicine. One significant barrier to the development of new medical radioisotopes is the difficulty of gaining access to radionuclides during the early stages of development and research. PRISMAP is a new medical radionuclide program designed to streamline that access for medical research in the European Union and the United Kingdom.

To continue reading, log in or create a free account!

Related Articles

The legacy of Windscale Pile No. 1

December 17, 2025, 9:29AMNuclear NewsJeremy Hampshire

The core of Pile No. 1 at Windscale caught fire in the fall of 1957. The incident, rated a level 5, “Accident with Wider Consequences,” by the International Nuclear and Radiological Event...

A focus on clean energy transition

October 14, 2025, 9:30AMANS Nuclear Cafe

Michigan-based consulting firm Ducker Carlisle has released a report that outlines projected developments and opportunities as well as potential problems in the global shift to cleaner power....